Is CLYM or CMPS more undervalued in 2026?

CirclFi compares Climb Bio, Inc. (CLYM) and COMPASS Pathways Plc - American (CMPS) using 13 institutional-grade valuation models. CLYM has a Quality of Company score of 4.2/10 while CMPS scores 1.9/10.

Which is a better buy — CLYM or CMPS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CLYM and CMPS valuations compare?

CLYM at $10.96 and CMPS at $13.06 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CLYM vs CMPS Valuation Comparison 2026 — Intrinsic Value Analysis

CLYM

Pharmaceutical Preparations

Climb Bio, Inc.

Quality

4.2

out of 10

Value Trap

SAFE

Price

$10.96

Last close

Models

7/13

Active

CMPS

Pharmaceutical Preparations

COMPASS Pathways Plc - American

Quality

1.9

out of 10

Value Trap

SAFE

Price

$13.06

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	CLYM Fair Value	CLYM Upside	CMPS Fair Value	CMPS Upside
Bayesian DCF	Intrinsic	$2.90	-73.5%	$2.95	-77.4%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$1.93	-82.4%	$5.77	-55.8%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	—	—	$14.06	+24.7%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CLYM vs CMPS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CLYM vs CMPS — Which Stock Is More Undervalued?

CLYM scores higher with a 4.2/10 quality rating vs CMPS's 1.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Climb Bio, Inc. (CLYM) and COMPASS Pathways Plc - American (CMPS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CLYM currently trades at $10.96 with a QOC of 4.2/10, while CMPS trades at $13.06 with a QOC of 1.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).